We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-11.33%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$15.1B
AUM Growth
-$1.81B
(-11%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
3.07%
Top 10 Holdings %
Top 10 Hldgs %
22.68%
Holding
1,302
New
77
Increased
452
Reduced
571
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$835M |
| 2 |
Procter & Gamble
PG
|
+$87.9M |
| 3 |
Alibaba
BABA
|
+$50.4M |
| 4 |
Merck
MRK
|
+$47.1M |
| 5 |
Target
TGT
|
+$42.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$105M |
| 2 |
Texas Instruments
TXN
|
+$79.4M |
| 3 |
TSMC
TSM
|
+$77.5M |
| 4 |
Cisco
CSCO
|
+$55.8M |
| 5 |
NextEra Energy
NEE
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.2% |
| 2 | Healthcare | 16.02% |
| 3 | Financials | 13.93% |
| 4 | Communication Services | 9.97% |
| 5 | Consumer Discretionary | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
CNO Financial Group
CNO
$5.1B
| $184K | ﹤0.01% |
12,485
-3,158
| -20% | -$57.6K |
|
977
Cerus
CERS
$474M
| $183K | ﹤0.01% |
37,500
-8,500
| -18% | -$49.3K |
|
978
Puma Biotechnology
PBYI
$454M
| $182K | ﹤0.01% |
8,500
-2,000
| -19% | -$60K |
|
979
Dell
DELL
$293B
| $180K | ﹤0.01% |
6,878
-56,323
| -89% | -$1.54M |
|
980
Freshpet
FRPT
$3.22B
| $180K | ﹤0.01% |
5,680
+1,026
| +22% | +$35.7K |
|
981
MacroGenics
MGNX
$257M
| $180K | ﹤0.01% |
14,300
-179,300
| -93% | -$3.01M |
|
|
GTHX
982
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $180K | ﹤0.01% |
9,400
-2,100
| -18% | -$78.7K |
|
983
Semtech
SMTC
$13B
| $179K | ﹤0.01% |
4,000
-2,400
| -38% | -$114K |
|
|
BPYU
984
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $179K | ﹤0.01% |
10,803
+5,352
| +98% | +$97.7K |
|
|
IDTI
985
DELISTED
Integrated Device Technology I
IDTI
| $179K | ﹤0.01% |
3,695
-48,533
| -93% | -$2.29M |
|
986
CytomX Therapeutics
CTMX
$754M
| $178K | ﹤0.01% |
12,100
-2,600
| -18% | -$38.6K |
|
|
AGR
987
DELISTED
Avangrid, Inc.
AGR
| $178K | ﹤0.01% |
3,553
-3,090
| -47% | -$152K |
|
988
Collegium Pharmaceutical
COLL
$956M
| $176K | ﹤0.01% |
10,800
-2,400
| -18% | -$41.1K |
|
989
Omeros
OMER
$959M
| $175K | ﹤0.01% |
15,400
-3,300
| -18% | -$46.2K |
|
|
ESL
990
DELISTED
Esterline Technologies
ESL
| $175K | ﹤0.01% |
1,430
+258
| +22% | +$29.8K |
|
991
Sunrun
RUN
$2.46B
| $174K | ﹤0.01% |
15,915
+2,870
| +22% | +$36.3K |
|
992
Revvity
RVTY
$12.8B
| $173K | ﹤0.01% |
2,230
-1,700
| -43% | -$144K |
|
993
Selective Insurance
SIGI
$5.73B
| $173K | ﹤0.01% |
2,900
| – | – |
|
|
CCXI
994
DELISTED
ChemoCentryx, Inc.
CCXI
| $173K | ﹤0.01% |
16,500
-3,500
| -18% | -$36.9K |
|
995
HEICO Corp Class A
HEI.A
$37.2B
| $171K | ﹤0.01% |
2,798
+1,186
| +74% | +$79.4K |
|
996
Molina Healthcare
MOH
$10.3B
| $171K | ﹤0.01% |
1,495
+269
| +22% | +$35.3K |
|
|
DMC
997
Del Monte Corp
DMC
$1.45B
| $168K | ﹤0.01% |
5,990
| – | – |
|
|
NE
998
DELISTED
Noble Corporation
NE
| $166K | ﹤0.01% |
62,000
| – | – |
|
|
MLNX
999
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $165K | ﹤0.01% |
+1,818
| New | +$154K |
|
1000
Knowles
KN
$3.34B
| $164K | ﹤0.01% |
12,400
| – | – |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2018 Portfolio in Review
As of Q4 2018, DekaBank Deutsche Girozentrale held 1,302 positions worth $15.1B, down 11% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
DekaBank Deutsche Girozentrale deployed $464M of net new capital in Q4 2018, opening 77 new positions and adding to 452 existing holdings. Its largest new stake was Linde: 5,283,074 shares worth $840M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $105M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2018 buy was Linde: 5,283,074 shares worth $840M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q4 2018, an estimated $87.9M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2018 reduction was Johnson & Johnson, cutting an estimated $105M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 23% of its $15.1B portfolio in Q4 2018.
- DekaBank Deutsche Girozentrale opened 77 new positions and closed 126 in Q4 2018.
- DekaBank Deutsche Girozentrale's portfolio value fell 11% quarter-over-quarter to $15.1B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2018, filed 12 Feb 2019.